South Africa is asking local drugmakers to start a process to make Gilead Sciences’ long-acting HIV prevention drug, ...

It's designed to take the place of complicated, multiple drug regimens that many people with HIV need to follow. And it's ...

South Africa is advocating for local production of Gilead Sciences’ HIV prevention drug lenacapavir. Collaborating with ...

Mr Ghebreyesus said a new medicine approved in 2025 for HIV prevention, Lenacapavir, represents the most significant development in combating HIV since the first antiretroviral treatments were ...

The federal government has announced that a new drug for HIV prevention, Lenacapavir, will arrive in Nigeria in March 2026.

Although HIV infection remains a global public health challenge, ART has transformed it from a fatal illness to a manageable lifetime condition for those who are successfully being treated.Initially, ...

Funding shortfalls prompt 18 states to cut costs, jeopardizing care for tens of thousands of Americans living with HIV.

South Africa is seeking to produce a key HIV prevention drug locally as part of a broader effort to improve access to treatment and strengthen the country’s pharmaceutical industry.

In tonight's programme, DR Congo forces launched drone strikes on M23 rebels near Rubaya, a key coltan mine, as militias ...

Zimbabwe introduces lenacapavir, a new HIV prevention drug administered twice a year, offering hope for high-risk groups but facing funding challenges.

South Africa has the world’s highest HIV burden, with about 8 million HIV-positive people, or 1 in 5 adults, as of last year.

Lenacapavir is an approved HIV treatment given as a twice-yearly injection. In 2025, Nigeria joined global leaders in announcing a historic price reduction for a revolutionary HIV prevention drug.